Abridge, a startup building artificial intelligence-powered clinical documentation tools, has raised $150 million in a Series C round, the company told Reuters, as more investors seek exposure to industry-specific generative AI applications.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in